📖 Check out our review about depression and chronic kidney disease
We discuss particularities in CKD patients, efficiency of antidepressants, uremic toxins, inflammations and novel therapeutic targets
@sburtey.bsky.social @aphm-chu-marseille.bsky.social
https://www.sciencedirect.com/science/article/pii/S0166432825000531?via%3Dihub